GTC presented abstracts at ASCO 2024
GTC’s posters from 2024 Convention of American Society of Clinical Oncology are now available to be downloaded. Please reach out with any questions.
Multiple Alternative Splicing of HER2 transcripts
and Exon Skipping with Potential
Consequences on Function and Antibody-Based Therapy
Using Cell-Free RNA in Monitoring Immune System and the Demonstration of Significant Systemic Deficiency in Lymphoid and Myeloid Biomarkers in Patients with Cancer
Read more Articles and News from GTC
Genomic Testing Cooperative to Exhibit and Present Research at 2026 ASCO Annual Meeting
GTC will spotlight DNA and RNA-based precision oncology testing, liquid biopsy applications and research across hematologic malignancies, breast cancer metastasis and CNS involvement CHICAGO, May
GTC and Dr. Maher Albitar Featured in Houston Business Journal
Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting
ASCO 2026 Abstracts
Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile. Presenter: Adam Albitar, MD
GTC opens Houston laboratory, expanding national precision oncology network
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic